Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KWY
1751
Kingsway Corp
KWY
$262M
| $3.13M | ﹤0.01% |
355,340
+25,025
| +8% | +$220K |
|
1752
Xencor
XNCR
$1.44B
| $3.12M | ﹤0.01% |
112,000
+8,700
| +8% | +$268K |
|
1753
Washington Trust Bancorp
WASH
$754M
| $3.12M | ﹤0.01% |
90,100
-24,368
| -21% | -$1.03M |
|
1754
Health Catalyst
HCAT
$164M
| $3.12M | ﹤0.01% |
267,069
+78,707
| +42% | +$1M |
|
1755
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
| $3.11M | ﹤0.01% |
61,518
-222,082
| -78% | -$11.1M |
|
|
ROIC
1756
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $3.1M | ﹤0.01% |
222,200
-374,800
| -63% | -$5.45M |
|
1757
LeMaitre Vascular
LMAT
$2.38B
| $3.09M | ﹤0.01% |
60,100
+7,700
| +15% | +$374K |
|
1758
Benchmark Electronics
BHE
$2.89B
| $3.09M | ﹤0.01% |
130,300
-28,400
| -18% | -$719K |
|
1759
Concrete Pumping Holdings
BBCP
$496M
| $3.08M | ﹤0.01% |
453,500
+25,200
| +6% | +$183K |
|
|
DICE
1760
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $3.08M | ﹤0.01% |
107,500
-13,800
| -11% | -$409K |
|
|
EFOR
1761
Everforth Inc
EFOR
$1.23B
| $3.08M | ﹤0.01% |
37,194
-98,800
| -73% | -$8.57M |
|
1762
Air T
AIRT
$82.1M
| $3.07M | ﹤0.01% |
122,711
-1,300
| -1% | -$30.1K |
|
1763
Harvard Bioscience
HBIO
$28.1M
| $3.07M | ﹤0.01% |
73,001
-430
| -0.6% | -$12.8K |
|
|
ALLK
1764
DELISTED
Allakos
ALLK
| $3.06M | ﹤0.01% |
687,374
+15,174
| +2% | +$97.1K |
|
1765
LifeVantage
LFVN
$80M
| $3.04M | ﹤0.01% |
846,318
-12,400
| -1% | -$46.6K |
|
1766
Beazer Homes USA
BZH
$887M
| $3.03M | ﹤0.01% |
191,028
-72,400
| -27% | -$1.07M |
|
1767
Brookfield Infrastructure
BIPC
$5.05B
| $3.03M | ﹤0.01% |
65,850
-36,600
| -36% | -$1.59M |
|
1768
Clearwater Paper
CLW
$352M
| $3.03M | ﹤0.01% |
90,700
+6,400
| +8% | +$231K |
|
1769
Lincoln Educational Services
LINC
$1.34B
| $3.02M | ﹤0.01% |
533,378
-3,100
| -0.6% | -$18.8K |
|
1770
Ashland
ASH
$3.29B
| $3.02M | ﹤0.01% |
29,375
-276,200
| -90% | -$28.7M |
|
1771
Bankunited
BKU
$3.4B
| $3.02M | ﹤0.01% |
133,600
+36,300
| +37% | +$1.18M |
|
1772
First Bancorp
FNLC
$401M
| $3.01M | ﹤0.01% |
116,263
+600
| +0.5% | +$17.2K |
|
|
PLYM
1773
DELISTED
Plymouth Industrial REIT
PLYM
| $3.01M | ﹤0.01% |
143,212
-56,000
| -28% | -$1.18M |
|
|
ABCM
1774
DELISTED
Abcam PLC
ABCM
| $3M | ﹤0.01% |
223,000
+104,951
| +89% | +$1.57M |
|
1775
MiMedx Group
MDXG
$637M
| $3M | ﹤0.01% |
879,585
+288,900
| +49% | +$1.12M |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.